CULLETTA, Giulia
CULLETTA, Giulia
Scienze e Tecnologie Biologiche Chimiche e Farmaceutiche
A comprehensive computational analysis of NR2F2/6 receptors for drug repurposing
2025-05-01 Giulia Culletta; Muhammad Sohaib Roomi; Anna Maria Almerico; Marco Tutone
A definitive pharmacophore modelling study on CDK2 ATP pocket binders: Tracing the path of new virtual high-throughput screenings
2020-01-01 Tutone M.; Culletta G.; Livecchi L.; Almerico A.M.
Aminoquinolines: Fluorescent sensors to DNA – A minor groove probe. Experimental and in silico studies
2023-10-01 de Carvalho Bertozo L.; Tutone M.; Pastrello B.; da Silva-Filho L.C.; Culletta G.; Almerico A.M.; Farias Ximenes V.
Beyond Nonsense: New Molecules as Precision Therapy for Rare Genetic Diseases
Pibiri, I.; Ricci, D.; Fiduccia, I.; Tutone, M.; Culletta, G.; Cruciata, I.; Menditto, M.; Subhan, F.; Varrica, R.; Vitale, E.; Rizzo, C.; Marino, S.; Melfi, R.; Zizzo, M.G.; Lentini, L.
Biophysical insights into the pathogenicity of rare genetic disease-associated proteins
2025-09-01 Vilasi, S.; Longo, L.; Randazzo, L.; Bollati, M.; Carrotta, R.; Costa, M.A.; De Rosa, M.; Mangione, M.R.; Martorana, V.; Culletta, G.; Tutone, M.; Mari, E.; Ortore, M.G.; Garcia-Franco, P.M.; Velazquez-Campoy, A.; Passantino, R.
CDK2 Allosteric Modulators: The New Route in the Design of New Drugs as Anticancer and Non-hormonal Contraceptives
2025-01-01 Culletta, G.; Almerico, A.M.; Tutone, M.
CHA on CDK2: a way to identify the best pharmacophore model for the virtual screening of new inhibitors
Chaperoning system: Intriguing target to modulate the expression of CFTR in cystic fibrosis
2024-08-28 Scalia F.; Culletta G.; Barreca M.; Caruso Bavisotto C.; Bivacqua R.; D'Amico G.; Alberti G.; Spano' V.; Tutone M.; Almerico A.M.; Cappello F.; Montalbano A.; Barraja P.
Comparing molecular dynamics-derived pharmacophore models with docking: A study on CDK-2 inhibitors
2020-01-01 Culletta G.; Almerico A.M.; Tutone M.
Design of small molecules and identification of putative anticancer therapeutic targets via in silico tools
2025-01-01 Marco Tutone; Giulia Culletta; Muhammad Sohaib Roomi; Mario Allegra; Davide Ricci; Michele Menditto; Ivana Pibiri; Laura Lentini
Design, Synthesis, Characterization, in Vitro Biological Evaluation, and in Silico Investigation of 4-Substituted Arylidene Pyrazolones Through Docking, Molecular Dynamics Simulations, and DFT Studies
2025-01-01 Addadi, R.; Ouici, H.B.; Boudou, F.; Berkane, A.; Guendouzi, A.; Brahim, H.; Boumediene, M.; Culletta, G.; Tutone, M.; Guendouzi, A.
Evaluation of the IKKβ Binding of Indicaxanthin by Induced-Fit Docking, Binding Pose Metadynamics, and Molecular Dynamics
2021-09-10 Allegra M.; Tutone M.; Tesoriere L.; Attanzio A.; Culletta G.; Almerico A.M.
Exploring the new non-covalent immunoproteasome inhibitors of β1i /β5i subunits: Virtual screening and in vitro test
2023-01-01 Giulia Culletta; Marco Tutone; Ugo Perricone; Carla Di Chio; Anna Maria Almerico; Maria Zappalà
Exploring the non-covalent ligand-binding mechanism on immunoproteasome by enhanced Molecular Dynamics
2021-01-01 Culletta Giulia; Zappalà Maria; Ettari Roberta; Almerico Anna Maria; Tutone Marco
Exploring the SARS-CoV-2 proteome in the search of potential inhibitors via structure-based pharmacophore modeling/docking approach
2020-01-01 Culletta G.; Gulotta M.R.; Perricone U.; Zappala M.; Almerico A.M.; Tutone M.
Fighting Antibiotic Resistance: New Pyrimidine-Clubbed Benzimidazole Derivatives as Potential DHFR Inhibitors
2023-01-04 Haque, M.; Marathakam, Akash; Rana, Ritesh; Almehmadi, Samar; Tambe, Vishal; Charde, Manoj; Islam, Fahadul; Siddiqui, Falak; Culletta, Giulia; Almerico, Anna; Tutone, Marco; Khan, Sharuk
FTSJ1 INHIBITION AS A STRATEGY FOR NONSENSE MUTATION SUPPRESSION IN TP53: INTEGRATIVE COMPUTATIONAL AND EXPERIMENTAL ANALYSIS
2025-01-01 Roomi, M.S.; Culletta, G.; Menditto, M.; Ricci, D.; Varrica, R.; Lentini, L.; Pibiri, I.; Almerico, A.M.; Tutone, M.
Immunoproteasome and Non-Covalent Inhibition: Exploration by Advanced Molecular Dynamics and Docking Methods
2021-07-02 Culletta, Giulia; Zappalà, Maria; Ettari, Roberta; Almerico, Anna Maria; Tutone, Marco
In Silico Design, Synthesis and Biological Evaluation of Anticancer Arylsulfonamide Endowed with Anti-Telomerase Activity
2022-01-10 Culletta G.; Allegra M.; Almerico A.M.; Restivo I.; Tutone M.
In silico-guided exploration of SIRT6 modulation: Discovery of new fragments hits inhibitors
2025-07-04 Sardo, I.; Culletta, G.; Perricone, U.; De Rosa, M.; Gulotta, M.R.; Spanò, V.; Barreca, M.; Steegborn, C.; Weyand, M.; Tutone, M.; Raimondi, M.V.
| Data di pubblicazione | Titolo | Autori | Tipologia | Autore(i) | File |
|---|---|---|---|---|---|
| 1-mag-2025 | A comprehensive computational analysis of NR2F2/6 receptors for drug repurposing | Giulia CullettaMuhammad Sohaib RoomiAnna Maria AlmericoMarco Tutone | 02 - Contributo in volume::2.08 Abstract in atti di convegno pubblicato in volume | Giulia Culletta; Muhammad Sohaib Roomi; Anna Maria Almerico; Marco Tutone | |
| 1-gen-2020 | A definitive pharmacophore modelling study on CDK2 ATP pocket binders: Tracing the path of new virtual high-throughput screenings | Tutone M.Culletta G.Almerico A. M. + | 01 - Contributo in rivista::1.01 Articolo in rivista | Tutone M.; Culletta G.; Livecchi L.; Almerico A.M. | |
| 1-ott-2023 | Aminoquinolines: Fluorescent sensors to DNA – A minor groove probe. Experimental and in silico studies | Tutone M.Culletta G.Almerico A. M. + | 01 - Contributo in rivista::1.01 Articolo in rivista | de Carvalho Bertozo L.; Tutone M.; Pastrello B.; da Silva-Filho L.C.; Culletta G.; Almerico A.M.; Farias Ximenes V. | |
| - | Beyond Nonsense: New Molecules as Precision Therapy for Rare Genetic Diseases | I. PibiriD. RicciI. FiducciaM. TutoneG. CullettaI. CruciataM. MendittoF. SubhanR. VarricaE. VitaleC. RizzoS. MarinoR. MelfiM. G. ZizzoL. Lentini | 06 - Intervento a convegno non pubblicato::6.2 Abstract non pubblicato | Pibiri, I.; Ricci, D.; Fiduccia, I.; Tutone, M.; Culletta, G.; Cruciata, I.; Menditto, M.; Subhan, F.; Varrica, R.; Vitale, E.; Rizzo, C.; Marino, S.; Melfi, R.; Zizzo, M.G.; Lentini, L. | |
| 1-set-2025 | Biophysical insights into the pathogenicity of rare genetic disease-associated proteins | Longo L.Randazzo L.Carrotta R.Mangione M. R.Culletta G.Tutone M.Passantino R. + | 02 - Contributo in volume::2.08 Abstract in atti di convegno pubblicato in volume | Vilasi, S.; Longo, L.; Randazzo, L.; Bollati, M.; Carrotta, R.; Costa, M.A.; De Rosa, M.; Mangione, M.R.; Martorana, V.; Culletta, G.; Tutone, M.; Mari, E.; Ortore, M.G.; Garcia-Franco, P.M.; Velazquez-Campoy, A.; Passantino, R. | |
| 1-gen-2025 | CDK2 Allosteric Modulators: The New Route in the Design of New Drugs as Anticancer and Non-hormonal Contraceptives | Culletta G.Almerico A. M.Tutone M. | 01 - Contributo in rivista::1.09 Review essay (rassegna critica) | Culletta, G.; Almerico, A.M.; Tutone, M. | |
| - | CHA on CDK2: a way to identify the best pharmacophore model for the virtual screening of new inhibitors | M. TutoneCULLETTA, GiuliaA. M. Almerico + | 06 - Intervento a convegno non pubblicato::6.3 Poster non pubblicato | - | |
| 28-ago-2024 | Chaperoning system: Intriguing target to modulate the expression of CFTR in cystic fibrosis | Scalia F.Culletta G.Barreca M.Caruso Bavisotto C.Bivacqua R.D'Amico G.Alberti G.Spano' V.Tutone M.Almerico A. M.Cappello F.Montalbano A.Barraja P. | 01 - Contributo in rivista::1.09 Review essay (rassegna critica) | Scalia F.; Culletta G.; Barreca M.; Caruso Bavisotto C.; Bivacqua R.; D'Amico G.; Alberti G.; Spano' V.; Tutone M.; Almerico A.M.; Cappello F.; Montalbano A.; Barraja P. | |
| 1-gen-2020 | Comparing molecular dynamics-derived pharmacophore models with docking: A study on CDK-2 inhibitors | Culletta G.Almerico A. M.Tutone M. | 01 - Contributo in rivista::1.01 Articolo in rivista | Culletta G.; Almerico A.M.; Tutone M. | |
| 1-gen-2025 | Design of small molecules and identification of putative anticancer therapeutic targets via in silico tools | Marco TutoneGiulia CullettaMuhammad Sohaib RoomiMario AllegraDavide RicciMichele MendittoIvana PibiriLaura Lentini | 02 - Contributo in volume::2.08 Abstract in atti di convegno pubblicato in volume | Marco Tutone; Giulia Culletta; Muhammad Sohaib Roomi; Mario Allegra; Davide Ricci; Michele Menditto; Ivana Pibiri; Laura Lentini | |
| 1-gen-2025 | Design, Synthesis, Characterization, in Vitro Biological Evaluation, and in Silico Investigation of 4-Substituted Arylidene Pyrazolones Through Docking, Molecular Dynamics Simulations, and DFT Studies | Culletta G.Tutone M. + | 01 - Contributo in rivista::1.01 Articolo in rivista | Addadi, R.; Ouici, H.B.; Boudou, F.; Berkane, A.; Guendouzi, A.; Brahim, H.; Boumediene, M.; Culletta, G.; Tutone, M.; Guendouzi, A. | |
| 10-set-2021 | Evaluation of the IKKβ Binding of Indicaxanthin by Induced-Fit Docking, Binding Pose Metadynamics, and Molecular Dynamics | Allegra M.Tutone M.Tesoriere L.Attanzio A.Culletta G.Almerico A. M. | 01 - Contributo in rivista::1.01 Articolo in rivista | Allegra M.; Tutone M.; Tesoriere L.; Attanzio A.; Culletta G.; Almerico A.M. | |
| 1-gen-2023 | Exploring the new non-covalent immunoproteasome inhibitors of β1i /β5i subunits: Virtual screening and in vitro test | Giulia CullettaMarco TutoneUgo PerriconeAnna Maria Almerico + | 02 - Contributo in volume::2.08 Abstract in atti di convegno pubblicato in volume | Giulia Culletta; Marco Tutone; Ugo Perricone; Carla Di Chio; Anna Maria Almerico; Maria Zappalà | |
| 1-gen-2021 | Exploring the non-covalent ligand-binding mechanism on immunoproteasome by enhanced Molecular Dynamics | Culletta GiuliaAlmerico Anna MariaTutone Marco + | 02 - Contributo in volume::2.08 Abstract in atti di convegno pubblicato in volume | Culletta Giulia; Zappalà Maria; Ettari Roberta; Almerico Anna Maria; Tutone Marco | |
| 1-gen-2020 | Exploring the SARS-CoV-2 proteome in the search of potential inhibitors via structure-based pharmacophore modeling/docking approach | Culletta G.Gulotta M. R.Perricone U.Almerico A. M.Tutone M. + | 01 - Contributo in rivista::1.01 Articolo in rivista | Culletta G.; Gulotta M.R.; Perricone U.; Zappala M.; Almerico A.M.; Tutone M. | |
| 4-gen-2023 | Fighting Antibiotic Resistance: New Pyrimidine-Clubbed Benzimidazole Derivatives as Potential DHFR Inhibitors | Culletta, GiuliaAlmerico, AnnaTutone, Marco + | 01 - Contributo in rivista::1.01 Articolo in rivista | Haque, M.; Marathakam, Akash; Rana, Ritesh; Almehmadi, Samar; Tambe, Vishal; Charde, Manoj; Islam, Fahadul; Siddiqui, Falak; Culletta, Giulia; Almerico, Anna; Tutone, Marco; Khan, Sharuk | |
| 1-gen-2025 | FTSJ1 INHIBITION AS A STRATEGY FOR NONSENSE MUTATION SUPPRESSION IN TP53: INTEGRATIVE COMPUTATIONAL AND EXPERIMENTAL ANALYSIS | Roomi M. S.Culletta G.Menditto M.Ricci D.Varrica R.Lentini L.Pibiri I.Almerico A. M.Tutone M. | 02 - Contributo in volume::2.09 Poster pubblicato in volume | Roomi, M.S.; Culletta, G.; Menditto, M.; Ricci, D.; Varrica, R.; Lentini, L.; Pibiri, I.; Almerico, A.M.; Tutone, M. | |
| 2-lug-2021 | Immunoproteasome and Non-Covalent Inhibition: Exploration by Advanced Molecular Dynamics and Docking Methods | Culletta, GiuliaAlmerico, Anna MariaTutone, Marco + | 01 - Contributo in rivista::1.01 Articolo in rivista | Culletta, Giulia; Zappalà, Maria; Ettari, Roberta; Almerico, Anna Maria; Tutone, Marco | |
| 10-gen-2022 | In Silico Design, Synthesis and Biological Evaluation of Anticancer Arylsulfonamide Endowed with Anti-Telomerase Activity | Culletta G.Allegra M.Almerico A. M.Restivo I.Tutone M. | 01 - Contributo in rivista::1.01 Articolo in rivista | Culletta G.; Allegra M.; Almerico A.M.; Restivo I.; Tutone M. | |
| 4-lug-2025 | In silico-guided exploration of SIRT6 modulation: Discovery of new fragments hits inhibitors | Sardo, IgnazioCulletta, GiuliaPerricone, UgoBarreca, MariliaTutone, MarcoRaimondi, Maria Valeria + | 01 - Contributo in rivista::1.01 Articolo in rivista | Sardo, I.; Culletta, G.; Perricone, U.; De Rosa, M.; Gulotta, M.R.; Spanò, V.; Barreca, M.; Steegborn, C.; Weyand, M.; Tutone, M.; Raimondi, M.V. |